Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials
Clinical trial NCT05492578 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05492578
- Sponsor
- Sanofi
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-22
- Primary completion
- 2029-01-22
- Enrollment
- 1663
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.